Tenet Healthcare Corp. Q1 2026 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2026. Tenet Healthcare Corporation operates a nationwide network of acute care and specialty hospitals (Hospital Operations) and ambulatory surgery centers (Ambulatory Care). As of the reporting date, the company operated 50 hospitals and held interests in 541 ambulatory surgery centers. A significant corporate event during the quarter was the execution of an "Omnibus Agreement" with CommonSpirit Health (formerly Catholic Health Initiatives) regarding the revenue cycle management subsidiary, Conifer Health Solutions.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Operating Revenues | $5,368 million | $5,223 million |
| Revenue from Contract Termination | $413 million | $0 |
| Operating Income | $1,296 million | $943 million |
| Net Income (Total) | $906 million | $622 million |
| Net Income to Common Shareholders | $702 million | $406 million |
| Diluted EPS | $8.01 | $4.27 |
| Operating Cash Flow | $1,641 million | $815 million |
| Cash and Equivalents (Ending) | $2,967 million | $2,999 million |
| Total Debt (Long-term + Current) | $13,209 million | $13,171 million |
| Adjusted EBITDA | $1,162 million | $1,163 million |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated net operating revenues increased 2.8% year-over-year. The Ambulatory Care segment drove this growth with a 10.6% increase, attributed to acquisitions and higher net revenue per case. Hospital Operations revenue grew 0.5%.
- Contract Termination Revenue: The company recognized $413 million in revenue from the termination of a revenue cycle management agreement with CommonSpirit Health. This non-recurring item significantly boosted operating income and net income.
- Profitability: Operating income margin expanded to 24.1% from 18.1% in the prior year, largely due to the contract termination revenue. Adjusted EBITDA remained flat at approximately $1.16 billion.
- Shareholder Returns: The company repurchased 1.346 million shares of common stock for $318 million. Additionally, the company redeemed CommonSpirit Health's minority interest in Conifer, resulting in a $549 million cash outflow for noncontrolling interest purchases.
- Operational Volumes: Total hospital admissions increased 0.7%, while total emergency department visits decreased 2.7%. Ambulatory Care consolidated cases increased 5.3%.
Outlook, Risks, and Management Commentary
- Strategic Focus: Management continues to prioritize expanding the Ambulatory Care segment through acquisitions and organic growth, citing higher margins compared to inpatient services. The company is also leveraging AI tools for clinical care coordination and revenue cycle management.
- Regulatory Risks: The filing highlights significant uncertainty regarding the "One Big Beautiful Bill Act" (OBBBA) enacted in July 2025. Provisions including Medicaid work requirements and caps on state-directed payments are expected to take effect in 2027, potentially leading to coverage losses and reduced payments. The company cannot currently estimate the financial impact.
- Capital Structure: The company maintains a fixed-rate debt structure with maturities staggered from 2027 to 2033. It has $1.9 billion available under its revolving credit facility, with no borrowings outstanding as of March 31, 2026.
- Capital Expenditures: CapEx for the quarter was $180 million. Full-year 2026 guidance is approximately $700 million to $800 million.
Investor Verification Checklist
- Non-Recurring Revenue: Verify the sustainability of earnings by excluding the $413 million contract termination revenue from CommonSpirit Health.
- Regulatory Impact: Monitor state-level implementation of the OBBBA and its potential effect on Medicaid reimbursement rates and patient volumes starting in 2027.
- Debt Maturities: Review the schedule of senior secured and unsecured notes maturing between 2027 and 2033 to assess refinancing risks.
- Acquisition Integration: Assess the performance of the $120 million in Ambulatory Care acquisitions completed in Q1 2026 and their contribution to the 10.6% segment revenue growth.
- Uninsured Costs: Track the rising trend in charity and uninsured admissions (up 10.1% year-over-year) and its impact on net patient service revenue.